Paula S. Farag

New 1,3,4-thiadiazoles as potential anticancer agents: pro-apoptotic, cell cycle arrest, molecular modelling, and ADMET profile

Mohamed H. Hekal, Paula S. Farag, Magdy M. Hemdan et al. · RSC Advances · 2023 · 31 citations · Full text

Annulated pyrazole derivatives as a novel class of urokinase (uPA) inhibitors: Green synthesis, anticancer activity, DNA-damage evaluation, and molecular modelling study

Paula S. Farag, Asmaa M. AboulMagd, Magdy M. Hemdan et al. · Bioorganic Chemistry · 2022 · 30 citations

Medicinal Chemistry, Biochemistry, Medicine +8

Design, microwave assisted synthesis, and molecular modeling study of some new 1,3,4-thiadiazole derivatives as potent anticancer agents and potential VEGFR-2 inhibitors

Saad R. Atta‐Allah, Asmaa M. AboulMagd, Paula S. Farag · Bioorganic Chemistry · 2021 · 28 citations

Combinatorial Chemistry, Medicinal Chemistry, Molecular Modeling Study +11

Design, synthesis and cytotoxic evaluation of new thieno[2,3-d]pyrimidine analogues as VEGFR-2/AKT dual inhibitors, apoptosis and autophagy inducers

Heba K. Abd El-Mawgoud, Asmaa M. AboulMagd, Mohamed T. M. Nemr et al. · Bioorganic Chemistry · 2024 · 26 citations

Medicinal Chemistry, Medicine, Vegfr-2/akt Dual Inhibitors +9

New N-(1,3,4-thiadiazol-2-yl)furan-2-carboxamide derivatives as potential inhibitors of the VEGFR-2

Mohamed H. Hekal, Paula S. Farag, Magdy M. Hemdan et al. · Bioorganic Chemistry · 2021 · 25 citations

Medicinal Chemistry, Medicine, Furan-2-carboxamide Derivatives +6